According to bulk deal data on the National Stock Exchange (NSE), Docon Technologies has sold a little over 53.32 lakh shares, or a 10.06 per cent stake, in the company.
The transaction was valued at approximately Rs 667.69 crore and was executed at an average price of Rs 1,252.03 per piece.
After the sale of the stake, Docon Technologies’ stake in Thyrocare Technologies fell from 71.06 percent to 61 percent.
Meanwhile, ICICI Prudential Mutual Fund (MF), Aditya Birla Sun Life MF, HDFC MF, HSBC MF and Eastspring Investments collectively bought 42.11 lakh shares, or a 7.95 per cent stake, at an average price of Rs 1,252 per share.
Eastspring Investments is a branch of the British multinational Prudential. This took the deal value to Rs 527.23 crore. Details of the other buyers of Thyrocare Technologies shares could not be ascertained on the NSE.
In a regulatory filing, Thyrocare Technologies on Friday said Docon Technologies Pvt Ltd, a promoter of the company, has sold 53,32,860 equity shares of the company through market transactions for a total gross consideration of Rs 667.69 crore.
The company sold approximately 10 percent of the total paid-up capital.
“Following this transaction, Docon will continue to be a promoter of the company. Following this transaction, the promoter’s shareholding in the company has been reduced to 60.93 percent from 70.98 percent before the transaction,” Thyrocare Technologies said.
Shares of Thyrocare Technologies rose 1.99 percent to close at Rs 1,269.70 apiece on the NSE.
#Thyrocare #promoter #sells #stake #crore